Overview

Scar-Improvement Efficacy and Safety of a Single Intradermal Injection of Avotermin (Juvista) Administered Following Full-Thickness Skin Incisions

Status:
Completed

Trial end date:
2007-03-01

Target enrollment:

Participant gender:

Summary

This study was undertaken to investigate the scar-improvement efficacy and safety of a single dose of avotermin (Juvista) injection into skin incisions.

Phase:

Phase 2

Details

Lead Sponsor:

Renovo

Treatments:

Mitogens